CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY: Form 990, tax year 2019
View the entire original 990 at ProPublica ↗
- Organization
- CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (EIN 31-1667995)
- Tax period
- 2019-01-01 to 2019-12-31
- Filed
- 2020-10-21
- IRS object ID
- 202042959349300814
- Schema version
- 2019v5.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2020-10-21T10:14:33-05:00 | ReturnTs |
| Tax Period End | 2019-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | BDO USA LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 8401 GREENSBORO DRIVE 800 | AddressLine1Txt |
| City | MCLEAN | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22102 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2019-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 311667995 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CONQUER CANCER FOUNDATION OF THE AMERICAN | BusinessNameLine1Txt |
| Business Name Line2 | SOCIETY OF CLINICAL ONCOLOGY | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % LINDA JENSEN CFO | InCareOfNm |
| Business Name Control | CONQ | BusinessNameControlTxt |
| Phone | 5714831700 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2318 MILL ROAD Suite 800 | AddressLine1Txt |
| City | ALEXANDRIA | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22314 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | LINDA JENSEN | PersonNm |
| Person Title | CFO | PersonTitleTxt |
| Phone | 5714831300 | PhoneNum |
| Signature | 2020-10-20 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | Marc Berger | PreparerPersonNm |
| PTIN | P01871563 | PTIN |
| Phone | 7038930600 | PhoneNum |
Filing Security Information FilingSecurityInformation
IP Address IPAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| I Pv4 Address | 73.53.153.141 | IPv4AddressTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Federal Original Submission Id | 54621820202955000001 | FederalOriginalSubmissionId |
| Federal Original Submission Id | 2020-10-21 | FederalOriginalSubmissionIdDt |
| Filing License Type | P | FilingLicenseTypeCd |
| At Submission Creation Device Id | F80C4C4CE64063363A32333BB37C43EAD2BBFD59 | AtSubmissionCreationDeviceId |
| At Submission Filing Device Id | F80C4C4CE64063363A32333BB37C43EAD2BBFD59 | AtSubmissionFilingDeviceId |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2019 | TaxYr |
| Build TS | 2021-01-29 14:40:06Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | CLIFFORD HUDIS MD | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2318 MILL ROAD SUITE 800 | AddressLine1Txt |
| City | ALEXANDRIA | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22314 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $33,401,732 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.CONQUER.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1999 | FormationYr |
| Legal Domicile State | VA | LegalDomicileStateCd |
| Activity Or Mission | CONQUERING CANCER WORLDWIDE BY FUNDING BREAKTHROUGH RESEARCH AND SHARING CUTTING-EDGE KNOWLEDGE. CONQUER CANCER'S VISION IS A WORLD FREE FROM THE FEAR OF CANCER. | ActivityOrMissionDesc |
| Voting Members Governing Body | 16 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 15 | VotingMembersIndependentCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Total Volunteers | 156 | TotalVolunteersCnt |
| Total Gross UBI | $522,500 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $269,300 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $31,933,505 | PYContributionsGrantsAmt |
| CY Contributions Grants | $27,209,762 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $522,500 | CYProgramServiceRevenueAmt |
| PY Investment Income | $1,229,060 | PYInvestmentIncomeAmt |
| CY Investment Income | $2,692,338 | CYInvestmentIncomeAmt |
| PY Other Revenue | $4,425 | PYOtherRevenueAmt |
| CY Other Revenue | $26,046 | CYOtherRevenueAmt |
| PY Total Revenue | $33,166,990 | PYTotalRevenueAmt |
| CY Total Revenue | $30,450,646 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $15,819,973 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $15,020,244 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $0 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $0 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $121,000 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $222,000 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $4,214,530 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $7,943,766 | PYOtherExpensesAmt |
| CY Other Expenses | $9,672,350 | CYOtherExpensesAmt |
| PY Total Expenses | $23,884,739 | PYTotalExpensesAmt |
| CY Total Expenses | $24,914,594 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $9,282,251 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $5,536,052 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $74,547,914 | TotalAssetsBOYAmt |
| Total Assets EOY | $89,666,380 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $4,353,781 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $7,196,521 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $70,194,133 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $82,469,859 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | CONQUER CANCER , THE ASCO FOUNDATION, FUNDS RESEARCH INTO EVERY FACET OF CANCER TO BENEFIT EVERY PATIENT, EVERYWHERE. IN 1964, SEVEN ONCOLOGISTS CREATED THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO), NOW A GLOBAL NETWORK OF NEARLY 45,000 CANCER PROFESSIONALS. AS ASCO'S FOUNDATION, CONQUER CANCER HELPS TURN SCIENCE INTO A SIGH OF RELIEF FOR PATIENTS AROUNDS THE WORLD BY SUPPORTING GROUNDBREAKING RESEARCH AND EDUCATION ACROSS CANCER'S FULL CONTINUUM. | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $6,690,010 | ExpenseAmt |
| Grant | $6,690,010 | GrantAmt |
| Desc | PROFESSIONAL EDUCATION - CONQUER CANCER HELPS ONCOLOGY PROFESSIONALS WORLDWIDE STAY UP TO DATE ON THE LATEST DEVELOPMENTS AND DISCOVERIES IN CANCER KNOWLEDGE. CONQUER CANCER SUPPORTS THE EFFORTS OF ASCO TO PROVIDE EDUCATION PROGRAMS IN THE US AND INTERNATIONALLY WHICH PROMOTE THE VITAL EXCHANGE OF IDEAS THAT LEAD TO WORLD-CLASS CARE, EVERYWHERE. FUNDS FROM CONQUER CANCER ARE USED TO SUPPORT ASCO'S COMPREHENSIVE SCIENTIFIC AND EDUCATIONAL PROGRAMS THROUGH BOTH LIVE MEETINGS AND PRINT AND ELECTRONIC EDUCATION OFFERINGS. HIGHLIGHTS OF THE PROFESSIONAL EDUCATIONAL AND SCIENTIFIC PROGRAMS SUPPORTED BY CONQUER CANCER AND PRESENTED TO THE PUBLIC IN 2019 INCLUDE THE FOLLOWING: * THE ASCO ANNUAL MEETING FEATURED NEARLY 265 EDUCATIONAL AND SCIENTIFIC SESSIONS. MORE THAN 5,000 ABSTRACTS WERE PRESENTED OR PUBLISHED. THE ASCO ANNUAL MEETING IS CONSIDERED THE PREMIER EDUCATIONAL AND SCIENTIFIC EVENT IN THE ONCOLOGY COMMUNITY AND ATTRACTS MORE THAN 40,000 ATTENDEES WORLDWIDE. THE MEETING OFFERS HEALTHCARE PROFESSIONALS PROVIDING ONCOLOGY CARE AN IMPORTANT OPPORTUNITY TO COME TOGETHER TO EXPLORE THE LATEST ADVANCES IN SCIENCE; CONTEXTUALIZE RECENT DISCOVERIES AND OPTIMIZE TREATMENT AND RESEARCH STRATEGIES; FRAME AND DISCUSS MAJOR CONTROVERSIES IN THE FIELD; AND NETWORK WITH PEERS IN AN ENVIRONMENT CHARGED WITH THE EXCITEMENT OF A COMMON GOAL: PROGRESS TOWARD BETTER OUTCOMES FOR PATIENTS. * GASTROINTESTINAL CANCERS (GI) SYMPOSIUM - THE ANNUAL GI SYMPOSIUM IS THE PREMIERE MULTIDISCIPLINARY GI CANCER SCIENTIFIC AND EDUCATIONAL MEETING. THE GI SYMPOSIUM GIVES HEALTHCARE PROVIDERS ACROSS MULTIPLE DISCIPLINES AND PROFESSIONS THE OPPORTUNITY TO RECEIVE CRITICAL UPDATES AND RECOMMENDATIONS TO IMPROVE THE CARE OF PATIENTS WITH GI CANCERS. THE SYMPOSIUM IS JOINTLY DEVELOPED BY A COMMITTEE WITH REPRESENTATIVES FROM THE AMERICAN GASTROENTEROLOGICAL ASSOCIATION INSTITUTE (AGA INSTITUTE), THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO), THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO), AND THE SOCIETY OF SURGICAL ONCOLOGY (SSO), WITH ADDITIONAL CONTENT ADVISORS FROM THE SOCIETY OF THORACIC SURGEONS (STS) AND THE AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES (AASLD). * GENITOURINARY CANCERS (GU) SYMPOSIUM - THE ANNUAL GU SYMPOSIUM IS THE PREEMINENT GENITOURINARY ONCOLOGY EVENT, ADDRESSING THE MULTIDISCIPLINARY NEEDS OF PHYSICIANS AND OTHER MEMBERS OF THE CANCER CARE AND RESEARCH COMMUNITY WHO DIAGNOSE, TREAT, AND STUDY GENITOURINARY MALIGNANCIES. THE GU SYMPOSIUM PROVIDES THE LATEST STRATEGIES IN SCREENING, DIAGNOSIS, TREATMENT, MANAGEMENT AND CONTROVERSIES IN THE FIELD OF GENITOURINARY CANCERS. THE SYMPOSIUM IS JOINTLY DEVELOPED BY COMMITTEES WITH REPRESENTATIVES FROM THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO), THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO), AND THE SOCIETY OF UROLOGIC ONCOLOGY (SUO). * BEST OF ASCO - WITH THE FIELD OF CANCER CARE CONSTANTLY EVOLVING AND EXPANDING, THE BEST OF ASCO MEETINGS BRING TOGETHER EXPERT FACULTY TO SYNTHESIZE THE MOST IMPORTANT RESEARCH AND CLINICAL DEVELOPMENTS PRESENTED AT THE ASCO ANNUAL MEETING AND TO DISCUSS PRACTICAL APPLICATIONS FOR PATIENT CARE. A PANEL OF ASCO EXPERTS SELECTS ABSTRACTS THAT HIGHLIGHT THE IMPORTANT SCIENTIFIC INFORMATION TO CREATE THE BEST OF ASCO MEETING PROGRAM. THIS PROGRAM PROVIDES ACCESS TO THE MOST CUTTING-EDGE, PRACTICE-CHANGING RESEARCH PRESENTED AT THE MEETING IN A RESPONSIBLE, PEER-REVIEWED MANNER. * SUPPORTIVE CARE IN ONCOLOGY SYMPOSIUM - THE SUPPORTIVE CARE IN ONCOLOGY SYMPOSIUM FOCUSES ON THE CONTINUUM OF SYMPTOM MANAGEMENT THROUGH ALL STAGES OF CANCER THERAPY. THE PROGRAM IS DESIGNED TO OFFER INSIGHTS INTO THE SCIENCE AND RESEARCH IN SUPPORTIVE CARE COMBINED WITH PRACTICAL GUIDANCE REGARDING IMPLEMENTATION OF BEST PRACTICES AND EVIDENCE-BASED CARE. THE PROGRAM INCORPORATES ABSTRACTS WITH THE LATEST FINDINGS, CHALLENGING CASES, AND AMPLE OPPORTUNITY FOR EXTENDED QUESTION AND ANSWER PERIODS AND MODERATED DISCUSSIONS THROUGHOUT. THE RESULT IS AN ENVIRONMENT WHERE EDUCATION AND SCIENCE OF SUPPORTIVE CARE ACROSS THE CONTINUUM COME TOGETHER TO MEET THE PRESSING NEEDS OF SUPPORTIVE CARE AND ONCOLOGY SPECILISTS ALIKE. THREE LEADING MEDICAL SPECIALITY SOCITIES COSPONSOR THE SUPPORTIVE CARE IN ONCOLOGY SYMPOSIUM: THE AMERICAN ACADEMY OF HOSPICE AND PALLIATIVE MEDICINE (AAHPM), THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO), AND THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO). *QUALITY CARE SYMPOSIUM - THE ASCO QUALITY CARE SYMPOSIUM PROVIDES A FORUM TO SHARE THE LATEST STRATEGIES AND METHODS FOR QUANTIFICATION OF PATIENT EXPERIENCE, PROVIDER EFFICIENCY, CLINICAL OUTCOMES, AND QUALITY AND SAFETY IN THE CANCER CARE FIELD. THE SYMPOSIUM BRINGS TOGETHER LEADERS IN THE FIELD TO SHARE STRATEGIES AND METHODS FOR MEASURING AND IMPROVING THE QUALITY OF CANCER CARE AND DISSEMINATES INFORMATION ON THE IMPROVEMENT OF THE QUALITY OF PATIENT AND SURVIVOR CARE THROUGH IMPLEMENTATION SCIENCE AND METHODS FOR QUANTIFICATION OF PATIENT EXPERIENCES, PROVIDER EFFICIENCY, CLINICAL OUTCOMES, SAFETY, AND VALUE. *IMMUNO-ONCOLOGY SYMPOSIUM - THE ASCO-SITC CLINICAL IMMUNO-ONCOLOGY SYMPOSIUM EXPLORES CLINICAL AND TRANSLATIONAL RESEARCH IN IMMUNO-ONCOLOGY AND IMPLICATIONS FOR PATIENT CARE. THE SYMPOSIUM FACILITATES IMPORTANT EDUCATIONAL AND SCIENTIFIC DIALOGUES ON CLINICAL DEVELOPMENTS ACROSS DISEASE SITES IN THE RAPIDLY ADVANCING FIELD OF IMMUNO-ONCOLOGY, AND HELPS MEET THE WIDESPREAD NEED FOR EDUCATION IN RESPONSE TO A PARADIGM SHIFT IN CANCER TREATMENT THAT TARGETS THE IMMUNE SYSTEM RATHER THAN THE TUMOR. THE SYMPOSIUM IS DEVELOPED BY THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) AND THE SOCIETY FOR THE IMMUNOTHERAPY OF CANCER (SITC). *ASCO/AACR METHODS IN CLINICAL CANCER RESEARCH WORKSHOP - SINCE 1996, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. (ASCO) AND THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) HAVE JOINTLY SPONSORED THE METHODS IN CLINICAL CANCER RESEARCH WORKSHOP. THE WORKSHOP OFFERS AN INTENSIVE LEARNING OPPORTUNITY FOR CLINICAL FELLOWS AND CLINICALLY-ORIENTED JUNIOR FACULTY RESEARCHERS IN ALL ONCOLOGY SUBSPECIALTIES. THE WORKSHOP COVERS THE ESSENTIALS OF EFFECTIVE CLINICAL TRIAL DESIGNS OF THERAPEUTIC INTERVENTIONS IN THE TREATMENT OF CANCER. HIGHLIGHTS OF PRINT AND ELECTRONIC PROFESSIONAL EDUCATION MATERIALS SUPPORTED BY CONQUER CANCER AND AVAILABLE TO THE PUBLIC IN 2019 INCLUDE THE FOLLOWING: *MEETING LIBRARY- ASCO'S MEETING LIBRARY IS A ONE-STOP LOCATION TO ACCESS ABSTRACTS, EDUCATIONAL BOOK MANUSCRIPTS, VIDEOS, SLIDES, AND POSTERS PRESENTED AT ASCO'S MEETINGS. ASCO'S MEETING LIBRARY IS AN INTEGRAL INFORMATIONAL AND EDUCATIONAL RESOURCE FOR ASCO MEMBERS, OTHER PHYSICIANS, PEOPLE WITH CANCER, AND THE GENERAL PUBLIC. THE ASCO MEETING LIBRARY BUNDLE INCLUDES THE FOLLOWING PRODUCTS: ABSTRACTS: ASCOS COMPREHENSIVE ONLINE DATABASE OF ONCOLOGY-RELATED RESEARCH ABSTRACTS FROM THE PREVIOUS 5 YEARS. INCLUDES LINKS TO RELATED PRESENTATIONS AND ADDITIONAL ABSTRACTS. VIDEOS AND SLIDES: ASCO VIDEOS AND SLIDES USE THE LATEST TECHNOLOGY TO DELIVER NEARLY 47,000 ORAL PRESENTATIONS AND ORAL ABSTRACTS FROM ASCO MEETINGS AND SYMPOSIA DATING BACK TO 2011. THE MOST COMPREHENSIVE COLLECTION OF ONCOLOGY-RELATED MEDIA IS AVAILABLE ONLINE FOR PHYSICIANS, RESEARCHERS, AND PATIENTS. MEETING POSTERS: POSTERS FROM GENERAL POSTER AND POSTER DISCUSSION SESSIONS FOR ASCO ANNUAL MEETING, GASTROINTESTINAL CANCERS SYMPOSIUM, GENITOURINARY CANCERS SYMPOSIUM, ASCO-SITC CLINICAL IMMUNO-ONCOLOGY SYMPOSIUM, CANCER SURVIVORSHIP SYMPOSIUM, ASCO QUALITY CARE SYMPOSIUM, AND THE SUPPORTIVE CARE IN ONCOLOGY SYMPOSIUM. ARCHIVED CONTENT IS AVAILABLE FOR MEETINGS NO LONGER OFFERED. *ASCO CLINICAL GUIDELINES MOBILE APPLICATION - ASCO DEVELOPS AND PUBLISHES CLINICAL PRACTICE GUIDELINES TO SERVE AS A GUIDE FOR DOCTORS AND OUTLINE APPROPRIATE METHODS OF TREATMENT AND CARE. THE GUIDELINES CAN ALSO ADDRESS SPECIFIC DISEASE-ORIENTED CLINICAL SITUATIONS, AS WELL AS USE OF APPROVED MEDICAL PRODUCTS, PROCEDURES, AND TESTS. THE ASCO CLINICAL PRACTICE GUIDELINES MOBILE APPLICATION IS DESIGNED TO MAKE ASCO GUIDELINES MORE USER FRIENDLY BY PROVIDING ACCESS AT THE BEDSIDE AND/OR IN CLINIC BY MEMBERS OF THE ONCOLOGY CARE TEAM, WITH THE ULTIMATE RESULT OF IMPROVING PATIENT CARE BASED ON ESTABLISHED SCIENCE AND THE LATEST RESEARCH. THE MOBILE APPLICATION IS AVAILABLE FOR THE APPLE IOS AND ANDROID OPERATING SYSTEMS, ACCESSIBLE BY SMARTPHONES AND TABLETS. INTERACTIVE TOOLS ARE ALSO INCLUDED WITHIN SOME GUIDELINES. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $10,853,950 | ExpenseAmt |
| Grant | $6,838,475 | GrantAmt |
| Desc | RESEARCH - THE CONQUER CANCER GRANTS & AWARDS PROGRAM HAS BEEN RECOGNIZING EXCELLENCE IN CLINICAL RESEARCH, QUALITY CARE, AND TEACHING IN THE FIELD OF ONCOLOGY SINCE 1984, WHEN THE PROGRAM ORIGINALLY BEGAN UNDER THE PURVIEW OF ASCO. CONQUER CANCER HAS A DEMONSTRATED TRACK RECORD IN SUPPORTING THE EARLY CAREER DEVELOPMENT OF ONCOLOGY RESEARCHERS, INCLUDING IDENTIFYING AND NURTURING THOSE WHO HAVE BECOME NOTABLE LEADERS AND INNOVATORS IN THE FIELD. PAST GRANT RECIPIENTS HAVE BECOME HEADS OF LARGE CANCER INSTITUTIONS AND PRESIDENTS OF MAJOR ONCOLOGY SOCIETIES, AS WELL AS GUIDED THE NATIONAL ONCOLOGY CONVERSATION THROUGH SERVICE ON BOARDS AND COMMITTEES. ADDITIONALLY, PAST RECIPIENTS HAVE ALSO INVESTED IN THE NEXT GENERATION OF YOUNG INVESTIGATORS BY SERVING AS MENTORS TO NEWLY CHOSEN CONQUER CANCER GRANTEES. CONQUER CANCER FUNDS THE ENTIRE SPECTRUM OF RESEARCH ACTIVITIES RELATED TO CANCER PREVENTION, SCREENING, TREATMENT, AND OUTCOMES RESEARCH IN ALL CANCER TYPES, AND SUPPORTS PROGRESS BY FUNDING CANCER RESEARCHERS AT ALL STAGES OF THEIR CAREERS, ENABLING ONCOLOGY'S BEST AND BRIGHTEST TO PURSUE PROMISING RESEARCH. EACH YEAR, CONQUER CANCER FUNDS AND AWARDS MULTIPLE RESEARCH GRANTS DESIGNED TO HELP ATTRACT AND RETAIN THE BEST SCIENTIFIC MINDS IN CANCER RESEARCH AND TO SUPPORT THEIR EFFORTS. CONQUER CANCER AND ASCO HAVE FUNDED MORE THAN $126 MILLION IN CANCER RESEARCH GRANTS TO OVER 2,100 RECIPIENTS IN 75 COUNTRIES. HIGHLIGHTS OF 2019 RESEARCH ACTIVITIES AND ACCOMPLISHMENTS INCLUDE: ADVANCED CLINICAL RESEARCH AWARD (ACRA) - $450,000 PROVIDED ONE (1) THREE-YEAR AWARD TO SUPPORT A PHYSICIAN-SCIENTIST COMMITTED TO PERFORMING ORIGINAL, CLINICAL CANCER RESEARCH IN BREAST CANCER. THIS RESEARCH MUST HAVE A PATIENT-ORIENTED FOCUS, INCLUDING A CLINICAL RESEARCH STUDY AND/OR TRANSLATIONAL RESEARCH INVOLVING HUMAN SUBJECTS. CAREER DEVELOPMENT AWARD (CDA) - $3,200,000 PROVIDED SIXTEEN(16) THREE-YEAR AWARDS INTENDED TO SUPPORT CLINICAL RESEARCH OF CLINICAL INVESTIGATORS WHO HAVE RECEIVED THEIR INITIAL FACULTY APPOINTMENTS AND ARE ESTABLISHING INDEPENDENT CLINICAL CANCER RESEARCH PROGRAMS. YOUNG INVESTIGATOR AWARD (YIA) - $3,800,000 PROVIDED SEVENTY-SIX (76) ONE-YEAR AWARDS DESIGNED TO ENCOURAGE AND PROMOTE HIGH-QUALITY RESEARCH IN CLINICAL ONCOLOGY BY PROVIDING FUNDS TO PROMISING INVESTIGATORS DURING THE TRANSITION FROM A FELLOWSHIP PROGRAM TO A FACULTY APPOINTMENT. GLOBAL ONCOLOGY YOUNG INVESTIGATOR AWARD - $300,000 PROVIDED SIX (6) ONE-YEAR AWARDS TO EARLY-CAREER INVESTIGATORS CONDUCTING RESEARCH IN LOW RESOURCE SETTINGS ON SCIENTIFIC QUESTIONS SPECIFIC TO THOSE SETTINGS, WITH THE POTENTIAL TO OFFER "REVERSE INNOVATION" INSIGHTS TO INFLUENCE ONCOLOGY PRACTICE IN A WIDE RANGE OF RESOURCE SETTINGS, BY INVESTIGATORS IN HIGH RESOURCE SETTINGS ON ISSUES IN RESOURCE-LIMITED SETTINGS, OR COLLABORATIVE RESEARCH BETWEEN INVESTIGATORS IN BOTH HIGH AND LOW RESOURCE SETTINGS ON QUESTIONS OF SHARED CONCERN. THE GOAL FOR THE GLOBAL ONCOLOGY YOUNG INVESTIGATOR AWARD IS TO ENCOURAGE AND PROMOTE QUALITY RESEARCH IN GLOBAL ONCOLOGY, AND TO DEVELOP THE NEXT GENERATION OF RESEARCHERS TO ADDRESS GLOBAL HEALTH NEEDS. THE JAMES B. NACHMAN JUNIOR FACULTY AWARD IN PEDIATRIC ONCOLOGY WAS ESTABLISHED IN MEMORY OF JAMES B. NACHMAN, MD, AN INTERNATIONALLY RENOWNED PEDIATRIC CANCER EXPERT AND PEDIATRICS PROFESSOR. HE CHAIRED SEVERAL CHILDREN'S ONCOLOGY GROUP NATIONAL STUDY COMMITTEES AND WAS AN AUTHORITY IN THE MEDICAL MANAGEMENT OF CHILDHOOD CANCERS, ESPECIALLY LEUKEMIA AND LYMPHOMA. $3,000 PROVIDED FOR ONE JUNIOR FACULTY MEMBER WITH THE HIGHEST SCORING ABSTRACT IN PEDIATRIC ONCOLOGY. MERIT AWARDS- $195,000 PROVIDED FOR ONE-HUNDRED NINETY-FOUR (194)MERIT AWARDS WHICH PROMOTE CLINICAL RESEARCH BY AWARDING YOUNG SCIENTISTS WHOSE RESEARCH IS ADDRESSED IN HIGH QUALITY ABSTRACTS SUBMITTED TO ASCO MEETINGS WITH AN OPPORTUNITY TO PRESENT THEIR RESEARCH AND INTERACT WITH OTHER CLINICAL CANCER INVESTIGATORS AT ASCO SCIENTIFIC MEETINGS AND DISEASE SPECIFIC SYMPOSIA. MEDICAL STUDENT ROTATION FOR UNDERREPRESENTED POPULATIONS (MSR)- $85,000 PROVIDED FOR TEN (10) MEDICAL STUDENT ROTATIONS. THE MSR PROVIDES A 4-WEEK CLINICAL OR CLINICAL RESEARCH ROTATION FOR U.S. MEDICAL STUDENTS FROM POPULATIONS UNDERREPRESENTED IN MEDICINE WHO ARE INTERESTED IN PURSUING ONCOLOGY AS A CAREER AND ALLOWS THEM TO GAIN KNOWLEDGE AND EXPERIENCE IN THE AREAS OF CLINICAL CANCER CARE AND RESEARCH. A MENTORING COMPONENT IS INCLUDED IN THE MSR WHEREBY AWARD RECIPIENTS ARE PAIRED WITH A CLINICAL ONCOLOGIST WHO PROVIDES ACADEMIC AND CAREER GUIDANCE, BOTH DURING AND FOLLOWING THE ROTATION EXPERIENCE. RESIDENT TRAVEL AWARD FOR UNDERREPRESENTED POPULATIONS - $9,000 PROVIDED FOR SIX (6) RESIDENT TRAVEL AWARDS (RTA). THE RTA PROVIDES FINANCIAL SUPPORT FOR RESIDENTS FROM UNDERREPRESENTED POPULATIONS TO ATTEND THE ASCO ANNUAL MEETING. ATTENDING THE ASCO ANNUAL MEETING GIVES PHYSICIAN RESIDENTS INTERESTED IN A CAREER IN ONCOLOGY THE OPPORTUNITY TO MEET ONCOLOGISTS AND TO LEARN MORE ABOUT CAREER OPTIONS IN THE FIELD. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $137,390 | ExpenseAmt |
| Grant | $137,390 | GrantAmt |
| Desc | QUALITY AND ACCESS TO CARE - REMARKABLE ADVANCES IN CANCER MEDICINE ARE OCCURRING MORE AND MORE FREQUENTLY, YET THE FULL PROMISE OF SUCH PROGRESS CANNOT BE REALIZED UNTIL HIGH QUALITY CANCER CARE IS AVAILABLE TO EVERYONE. CONQUER CANCER IS KEENLY AWARE OF THE POTENTIALLY FATAL DIVIDE BETWEEN THOSE WITH ACCESS TO THE FRUITS OF RESEARCH AND TIMELY CARE AND THOSE WITHOUT. WE SEEK TO CONFRONT THESE DISPARITIES AND IMPROVE THE OUTLOOK FOR EVERY PERSON TOUCHED BY CANCER BY SUPPORTING PROGRAMS THAT INCREASE ACCESS TO CARE IN ALL COMMUNITIES, INCLUDING THOSE UNDERSERVED. THE QUALITY AND ACCESS TO CARE PROGRAMS AND INITIATIVES SUPPORTED BY CONQUER CANCER IN 2019 INCLUDE THE FOLLOWING: DIVERSITY IN ONCOLOGY INITIATIVE - THE CONQUER CANCER GRANTS AND AWARDS PROGRAM PROVIDES FUNDING FOR DIFFERENT TYPES OF AWARD OPPORTUNTIES FOR ONCOLOGY FELLOWS, CLINICAL PRACTICES, AND INTERNATIONAL RESEARCHERS. ONE OF THE PROGRAMS OFFERED THROUGH CONQUER CANCER IS THE DIVERSITY IN ONCOLOGY INITIATIVE. THE DIVERSITY IN ONCOLOGY INITIATIVE WAS STRUCTURED TO FACILIATE THE RECRUITMENT AND RETENTION OF INDIVIDUALS FORM POPULATIONS UNDERREPRESENTED IN MEDICINE TO CANCER CAREERS, WITH PARTICULAR ATTENTION TO THE DEVELOPMENT OF CLINICAL PRACTITIONERS AND INVESTIGATORS. THE DIVERSITY IN ONCOLOGY PROGRAM CONSISTS OF AWARD OPPORTUNITIES FOR MEDICAL STUDENTS AND RESIDENTS WHO SELF-IDENTITY AS BEING MEMBERS OF UNDERREPRESENTED POPULATIONS. TWO AWARD OPPORTUNITIES ARE AVAILABLE: THE MEDICAL STUDENT ROTATION FOR UNDERREPRESENTED POPULATIONS (MSR) AND THE RESIDENT TRAVEL AWARD FOR UNDERREPRESENTED POPULATIONS. THE MSR PROVIDES A 4-WEEK CLINICAL OR CLINICAL RESEARCH ROTATION FOR U.S. MEDICAL STUDENTS FROM POPULATIONS UNDERREPRESENTED IN MEDICINE WHO ARE INTERESTED IN PURSUING ONCOLOGY AS A CAREER AND ALLOWS THEM TO GAIN KNOWLEDGE AND EXPERIENCE IN THE AREAS OF CLINICAL CANCER CARE AND RESEARCH. A MENTORING COMPONENT IS INCLUDED IN THE MSR WHEREBY AWARD RECIPIENTS ARE PAIRED WITH A CLINICAL ONCOLOGIST WHO PROVIDES ACADEMIC AND CAREER GUIDANCE, BOTH DURING AND FOLLOWING THE ROTATION EXPERIENCE. $85,000 PROVIDED FOR TEN (10) MEDICAL STUDENT ROTATIONS. THE RESIDENT TRAVEL AWARD PROVIDES FINANCIAL SUPPORT TO RESIDENTS FROM UNDERREPRESENTED POPULATIONS TO ATTEND THE ASCO ANNUAL MEETING. ATTENDING THE ASCO ANNUAL MEETING GIVES PHYSICIAN RESIDENTS INTERESTED IN A CAREER IN ONCOLOGY THE OPPORTUNITY TO MEET ONCOLOGISTS AND TO LEARN MORE ABOUT CAREER OPTIONS IN THE FIELD. $9,000 PROVIDED FOR SIX (6) RESIDENT TRAVEL AWARDS. *QUALITY TRAINING PROGRAM - AS THE LEADING ONCOLOGY QUALITY IMPROVEMENT (QI) COURSE, ASCO'S QUALITY TRAINING PROGRAM EMPOWERS PRACTICE TEAMS TO IMPROVE CLINICAL CARE AND OPERATIONAL PERFORMANCE BY TEACHING TEAMS HOW TO BALANCE QUALITY IMPROVEMENT PROJECTS WITH DEMANDING SCHEDULES AND COMPETING PRIORITIES. CONTENT HAS BEEN DEVELOPED SPECIFICALLY FOR ONCOLOGY PRACTICE TEAMS AND INCLUDES ACCESS TO RENOWNED FACULTY AND COACHES DURING FIVE FOCUSED DAYS OF IN-PERSON LEARNING. DURING THOSE FIVE DAYS, PRACTICE TEAMS ATTEND THREE SESSIONS, WHICH INCLUDE SEMINARS, CASE EXAMPLES, ADN SMALL GROUP EXERCISES. LEARNING CONTINUES THROUGHOUT THE SIX-MONTH COURSE, INCLUDING REMOTE COACHING SESSIONS AS NEEDED. EACH TEAM WILL TAKE ITS QUALITY IMPROVEMENT KNOWLEDGE AND SKILLS TO ANOTHER LEVEL, ACCELERATING CHANGE AND IMPROVEMENT. TEAMS WILL WORK ON A PROBLEM OF THEIR OWN CHOOSING, WHICH COULD RANGE FROM IMPROVING CARE COORDINATION OR PATIENT SAFETY TO A SPECIFIC ORAL CHEMOTHERAPY PROJECT. | Desc |
Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $1,354,369 | ExpenseAmt |
| Grant | $1,354,369 | GrantAmt |
| Desc | PATIENT EDUCATION & INFORMATION | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $1,354,369 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Grant | $1,354,369 | TotalOtherProgSrvcGrantAmt |
| Total Program Service Expenses | $19,035,719 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | false | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | Yes (true) | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | false | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | false | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (true) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (true) | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | false | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (true) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | Yes (true) | MoreThan5000KToIndividualsInd |
| Professional Fundraising | Yes (true) | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (true) | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | Yes (true) | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | false | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (true) | DeductibleNonCashContriInd |
| Deductible Art Contribution | Yes (true) | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | false | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 21 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 0 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | Yes (true) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (true) | Form990TFiledInd |
| Foreign Financial Account | false | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (true) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (true) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | false | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | false | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 16 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 15 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (true) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | Yes (true) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | Yes (true) | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | false | CompensationProcessCEOInd |
| Compensation Process Other | false | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AZ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | DC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ME | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ND | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | LINDA JENSEN CFO | PersonNm |
| Phone | 5714831320 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2318 MILL ROAD STE 800 | AddressLine1Txt |
| City | ALEXANDRIA | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22314 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (19 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt |
|---|---|---|---|---|---|---|---|
| Clifford Hudis MD FAC | |||||||
| CEO | 7.5 | 30.0 | Yes (X) | Yes (X) | $0 | $898,194 | $24,233 |
| LINDA JENSEN CPA | |||||||
| CFO | 7.5 | 30.0 | Yes (X) | $0 | $401,924 | $38,536 | |
| Nancy Daly MS MPH | |||||||
| EXEC VP & CHIEF PHILAN OFFICER | 36.5 | 1.0 | Yes (X) | $0 | $387,673 | $38,537 | |
| Thomas Roberts Jr M | |||||||
| Chair | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 |
| Sandra Swain MD FACP | |||||||
| Treasurer | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 |
| Claire A Huang | |||||||
| Secretary | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 |
| Alexander W Casdin | |||||||
| Board Member | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |
| Howard A Burris III | |||||||
| Board Member | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |
| Thomas Marsland MD F | |||||||
| Board Member | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |
| Lawrence H Einhorn M | |||||||
| Board Member | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |
| W Charles Penley MD | |||||||
| Board Member | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |
| Raj Mantena RPh | |||||||
| Board Member | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |
| Robert Mayer MD FASC | |||||||
| Board Member | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |
| Margaret Tempero MD | |||||||
| Board Member | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |
| Steven Rosen MD FACP | |||||||
| Board Member | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |
| Gerald J McDougall | |||||||
| Board Member | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |
| Susan L Cohn MD FAS | |||||||
| Board Member | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |
| Riccardo Braglia | |||||||
| Board Member | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |
| Craig R Nichols MD FA | |||||||
| Board Member | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $0 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $1,687,791 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $101,306 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 0 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (2 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| TRUE NORTH INC | |||||
| 630 3RD AVENUE 12TH FLOOR | NEW YORK | NY | 10017 | FUND. MESS & STRAT. | $886,500 |
| STRATUSLIVE | |||||
| 6465 COLLEGE PARK SQUARE SUITE 400 | VIRGINIA BEACH | VA | 23464 | DONORMGMT IT SERV. | $220,309 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 2 | CntrctRcvdGreaterThan100KCnt |
| Federated Campaigns | $7,015 | FederatedCampaignsAmt |
| Membership Dues | $736,500 | MembershipDuesAmt |
| Fundraising | $1,196,282 | FundraisingAmt |
| Related Organizations | $4,914,000 | RelatedOrganizationsAmt |
| All Other Contributions | $20,355,965 | AllOtherContributionsAmt |
| Noncash Contributions | $1,995,522 | NoncashContributionsAmt |
| Total Contributions | $27,209,762 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | ADVERTISING | Desc |
| Business | 900009 | BusinessCd |
| Total Revenue Column | $522,500 | TotalRevenueColumnAmt |
| Unrelated Business Revenue | $522,500 | UnrelatedBusinessRevenueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $522,500 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $2,667,684 | TotalRevenueColumnAmt |
| Exclusion | $2,667,684 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $2,895,613 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $2,870,959 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $24,654 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $24,654 | TotalRevenueColumnAmt |
| Exclusion | $24,654 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $106,173 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $1,196,282 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $80,127 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $26,046 | TotalRevenueColumnAmt |
| Exclusion | $26,046 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gaming Gross Income | $0 | GamingGrossIncomeAmt |
| Gaming Direct Expenses | $0 | GamingDirectExpensesAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales Of Inventory | $0 | GrossSalesOfInventoryAmt |
| Cost Of Goods Sold | $0 | CostOfGoodsSoldAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $0 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $30,450,646 | TotalRevenueColumnAmt |
| Unrelated Business Revenue | $522,500 | UnrelatedBusinessRevenueAmt |
| Exclusion | $2,718,384 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $13,574,321 | TotalAmt |
| Program Services | $13,574,321 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $338,100 | TotalAmt |
| Program Services | $338,100 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,107,823 | TotalAmt |
| Program Services | $1,107,823 | ProgramServicesAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $0 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,926,708 | TotalAmt |
| Program Services | $2,603,483 | ProgramServicesAmt |
| Management And General | $869,662 | ManagementAndGeneralAmt |
| Fundraising | $2,453,563 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,504 | TotalAmt |
| Management And General | $6,504 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $41,574 | TotalAmt |
| Management And General | $41,574 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $222,000 | TotalAmt |
| Fundraising | $222,000 | FundraisingAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $33,191 | TotalAmt |
| Management And General | $33,191 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $525,064 | TotalAmt |
| Program Services | $359,722 | ProgramServicesAmt |
| Management And General | $75,408 | ManagementAndGeneralAmt |
| Fundraising | $89,934 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $160,682 | TotalAmt |
| Program Services | $97,995 | ProgramServicesAmt |
| Management And General | $34,965 | ManagementAndGeneralAmt |
| Fundraising | $27,722 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,121,784 | TotalAmt |
| Program Services | $45,554 | ProgramServicesAmt |
| Management And General | $364,287 | ManagementAndGeneralAmt |
| Fundraising | $711,943 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $649,286 | TotalAmt |
| Program Services | $473,615 | ProgramServicesAmt |
| Management And General | $68,816 | ManagementAndGeneralAmt |
| Fundraising | $106,855 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $298,050 | TotalAmt |
| Program Services | $199,668 | ProgramServicesAmt |
| Management And General | $15,960 | ManagementAndGeneralAmt |
| Fundraising | $82,422 | FundraisingAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $197,221 | TotalAmt |
| Program Services | $53,253 | ProgramServicesAmt |
| Management And General | $65,784 | ManagementAndGeneralAmt |
| Fundraising | $78,184 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Expenses OtherExpensesGrp (3 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| POSTAGE | $227,816 | $50,991 | $4,785 | $172,040 |
| PRINTING | $385,237 | $110,155 | $7,749 | $267,333 |
| OTHER EXPENSES | $99,233 | $21,039 | $75,660 | $2,534 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $24,914,594 | TotalAmt |
| Program Services | $19,035,719 | ProgramServicesAmt |
| Management And General | $1,664,345 | ManagementAndGeneralAmt |
| Fundraising | $4,214,530 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,246,912 | BOYAmt |
| EOY | $5,649,132 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,889,011 | BOYAmt |
| EOY | $6,312,068 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $889 | BOYAmt |
| EOY | $610 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $188,502 | BOYAmt |
| EOY | $297,353 | EOYAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $56,118,569 | BOYAmt |
| EOY | $76,413,045 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,104,031 | BOYAmt |
| EOY | $994,172 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $74,547,914 | BOYAmt |
| EOY | $89,666,380 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $458,665 | BOYAmt |
| EOY | $299,017 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,857,504 | BOYAmt |
| EOY | $3,072,066 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,037,612 | BOYAmt |
| EOY | $3,825,438 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,353,781 | BOYAmt |
| EOY | $7,196,521 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $35,258,849 | BOYAmt |
| EOY | $40,974,084 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $34,935,284 | BOYAmt |
| EOY | $41,495,775 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $70,194,133 | BOYAmt |
| EOY | $82,469,859 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $74,547,914 | BOYAmt |
| EOY | $89,666,380 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $5,536,052 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $6,739,674 | NetUnrlzdGainsLossesInvstAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consol And Sep Basis Fincl Stmt | Yes (X) | ConsolAndSepBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | false | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $29,974,390 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $23,158,842 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $29,032,906 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $31,998,377 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $27,209,762 | CurrentTaxYearAmt |
| Total | $141,374,277 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $29,974,390 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $23,158,842 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $29,032,906 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $31,998,377 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $27,209,762 | CurrentTaxYearAmt |
| Total | $141,374,277 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $39,649,136 | SubstantialContributorsTotAmt |
| Public Support Total170 | $101,725,141 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $833,497 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $877,067 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $908,055 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $719,934 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $2,667,684 | CurrentTaxYearAmt |
| Total | $6,006,237 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year | $269,300 | CurrentTaxYearAmt |
| Total | $269,300 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $147,649,814 | TotalSupportAmt |
| Public Support CY170 | 0.68896 | PublicSupportCY170Pct |
| Public Support PY170 | 0.67671 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Art Public Exhibition Amounts | ArtPublicExhibitionAmountsGrp | |
| Held Works Art | HeldWorksArtGrp |
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $17,571,755 | BeginningYearBalanceAmt |
| Contributions | $8,235,901 | ContributionsAmt |
| Investment Earnings Or Losses | $2,772,005 | InvestmentEarningsOrLossesAmt |
| Grants Or Scholarships | $839,500 | GrantsOrScholarshipsAmt |
| End Year Balance | $27,740,161 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $17,114,411 | BeginningYearBalanceAmt |
| Contributions | $2,133,374 | ContributionsAmt |
| Investment Earnings Or Losses | -$964,377 | InvestmentEarningsOrLossesAmt |
| Grants Or Scholarships | $711,653 | GrantsOrScholarshipsAmt |
| End Year Balance | $17,571,755 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $10,363,214 | BeginningYearBalanceAmt |
| Contributions | $6,170,675 | ContributionsAmt |
| Investment Earnings Or Losses | $1,125,396 | InvestmentEarningsOrLossesAmt |
| Grants Or Scholarships | $544,874 | GrantsOrScholarshipsAmt |
| End Year Balance | $17,114,411 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $9,169,527 | BeginningYearBalanceAmt |
| Contributions | $1,364,000 | ContributionsAmt |
| Investment Earnings Or Losses | $280,187 | InvestmentEarningsOrLossesAmt |
| Grants Or Scholarships | $450,500 | GrantsOrScholarshipsAmt |
| End Year Balance | $10,363,214 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $3,968,976 | BeginningYearBalanceAmt |
| Contributions | $5,417,500 | ContributionsAmt |
| Investment Earnings Or Losses | -$94,449 | InvestmentEarningsOrLossesAmt |
| Grants Or Scholarships | $122,500 | GrantsOrScholarshipsAmt |
| End Year Balance | $9,169,527 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prmnnt Endowment Balance EOY | 1.00000 | PrmnntEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | false | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | false | EndowmentsHeldRelatedOrgInd |
| Land | LandGrp | |
| Buildings | BuildingsGrp | |
| Leasehold Improvements | LeaseholdImprovementsGrp | |
| Equipment | EquipmentGrp | |
| Other Land Buildings | OtherLandBuildingsGrp | |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
| Total Liability | $0 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $37,237,256 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $6,739,674 | NetUnrealizedGainsInvstAmt |
| Revenue Not Reported | $6,739,674 | RevenueNotReportedAmt |
| Revenue Subtotal | $30,497,582 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $33,191 | InvestmentExpensesNotIncldAmt |
| Other Revenues Not Included | -$80,127 | OtherRevenuesNotIncludedAmt |
| Revenue Not Reported Fincl Stmt | -$46,936 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $30,450,646 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $24,961,530 | TotExpnsEtcAuditedFinclStmtAmt |
| Other Expenses Included | $80,127 | OtherExpensesIncludedAmt |
| Expenses Not Reported | $80,127 | ExpensesNotReportedAmt |
| Expenses Subtotal | $24,881,403 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $33,191 | InvestmentExpensesNotIncld2Amt |
| Expenses Not Rpt Fincl Stmt | $33,191 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $24,914,594 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (5 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART V, LINE 4 | Permanently restricted net assets of donor-restricted endowment funds are preserved, absent explicit direction from the donor. Interest from the permanently restricted funds is intended to fund future research and/or educational awards. |
| PART V, LINE 1A-1G | ENDOWMENT FUNDS ARE BASED ON GAAP AND AGREE TO THE RESTRICTED FUNDS ON THE AUDITED FINANCIAL STATEMENTS. |
| PART X, LINE 2 | IN ACCORDANCE WITH GAAP, THE FOUNDATION MAY RECOGNIZE THE TAX BENEFIT FROM AN UNCERTAIN TAX POSITION ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITION WILL BE SUSTAINED AN EXAMINATION BY TAXING AUTHORITIES, BASED ON THE TECHNICAL MERITS OF THE POSITION. THE TAX BENEFITS RECOGNIZED IN THE FINANCIAL STATEMENTS FROM SUCH A POSITION ARE MEASURED BASED ON THE LARGEST BENEFIT THAT HAS A GREATER THAN 50% LIKELIHOOD OF BEING REALIZED UPON ULTIMATE SETTLEMENT. THE FOUNDATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR TAX POSITIONS TAKEN, AND THEREFORE, DOES NOT HAVE UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS. GENERALLY, THE FOUNDATION IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY THE U.S. FEDERAL, STATE OR LOCAL TAX AUTHORITIES FOR YEARS BEFORE DECEMBER 31, 2016. |
| PART XII, LINE 4b | FUNDRAISING EXPENSES $80,127 |
| PART XI, LINE 2d | FUNDRAISING EXPENSES $80,127 |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (7 entries)
| RegionRegionTxt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|
| East Asia and the Pacific | Program Services | Awards & Grants | $46,625 |
| Europe (Including Iceland and Greenland) | Program Services | AWARDS & GRANTS | $143,800 |
| North America | Program Services | AWARDS & GRANTS | $471,000 |
| South America | Program Services | AWARDS & GRANTS | $326,600 |
| Sub-Saharan Africa | Program Services | AWARDS & GRANTS | $29,880 |
| South Asia | Program Services | AWARDS & GRANTS | $57,118 |
| Middle East and North Africa | Program Services | AWARDS & GRANTS | $2,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Spent | $1,077,023 | SubtotalSpentAmt |
| Total Spent | $1,077,023 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (12 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt |
|---|---|---|---|
| North America | Career Development Award | $200,000 | CHECK |
| North America | Career Development Award | $200,000 | CHECK |
| Central America and the Caribbean | Career Development Award | $200,000 | CHECK |
| Central America and the Caribbean | GLOBOL ONCOL | $50,000 | CHECK |
| Central America and the Caribbean | GLOBAL ONCOL | $50,000 | CHECK |
| Europe (Including Iceland and Greenland) | GLOBOL ONCOL | $50,000 | CHECK |
| South Asia | INT'L INNOVATION | $20,000 | CHECK |
| South Asia | INT'L INNOVATION | $20,000 | CHECK |
| Sub-Saharan Africa | INT'L INNOVATION | $20,000 | CHECK |
| Central America and the Caribbean | INT'L INNOVATION | $20,000 | CHECK |
| North America | YOUNG INVEST | $50,000 | CHECK |
| Europe (Including Iceland and Greenland) | YOUNG INVEST | $50,000 | CHECK |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Org | 12 | TotalOtherOrgCnt |
Foreign Individuals Grants ForeignIndividualsGrantsGrp (13 entries)
| Type Of AssistanceTypeOfAssistanceTxt | RegionRegionTxt | RecipientRecipientCnt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt |
|---|---|---|---|---|
| PATIENT ADVOCATE | East Asia and the Pacific | 1 | $2,200 | CHECK |
| PATIENT ADVOCATE | Europe (Including Iceland and Greenland) | 1 | $2,200 | CHECK |
| PATIENT ADVOCATE | Europe (Including Iceland and Greenland) | 1 | $2,200 | CHECK |
| PATIENT ADVOCATE | Europe (Including Iceland and Greenland) | 1 | $2,200 | CHECK |
| PATIENT ADVOCATE | Europe (Including Iceland and Greenland) | 1 | $2,200 | CHECK |
| PATIENT ADVOCATE | Europe (Including Iceland and Greenland) | 1 | $2,200 | CHECK |
| PATIENT ADVOCATE | Central America and the Caribbean | 1 | $2,200 | CHECK |
| PATIENT ADVOCATE | North America | 1 | $2,200 | CHECK |
| PATIENT ADVOCATE | South Asia | 1 | $2,200 | CHECK |
| PATIENT ADVOCATE | South Asia | 1 | $2,200 | CHECK |
| PATIENT ADVOCATE | Sub-Saharan Africa | 1 | $2,200 | CHECK |
| PATIENT ADVOCATE | Sub-Saharan Africa | 1 | $2,200 | CHECK |
| PATIENT ADVOCATE | Sub-Saharan Africa | 1 | $2,200 | CHECK |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Transfer To Foreign Corp | false | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | false | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | false | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | EXPLANATION: CONQUER CANCER GRANTS ARE AWARDED BASED ON MERIT THROUGH A PEER-REVIEW PROCESS CONDUCTED BY MEMBERS OF CONQUER CANCER'S GRANT SELECTION COMMITTEE USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH SPECIFIC GRANT. GRANTEES ARE REQUIRED TO SIGN A GRANT AGREEMENT THAT ESTABLISHES CERTAIN REQUIREMENTS FOR THE GRANT. GRANTEES MUST REQUEST APPROVAL FOR ANY CHANGES IN THE GRANT PROJECT AND THE GRANTEE'S STATUS. GRANTEES MUST SUBMIT A FORMAL REQUEST FOR A CHANGE IN OBJECTIVES OR SCOPE AND INCLUDE JUSTIFICATION FOR THE CHANGES, WHICH IS SUBJECT TO CONQUER CANCER'S REVIEW AND APPROVAL. GRANTEES ARE REQUIRED TO NOTIFY CONQUER CANCER AND REQUEST A NO-COST EXTENSION IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT OR TO MEET THE PROPOSED TIME SCHEDULES. GRANTEES ARE REQUIRED TO NOTIFY CONQUER CANCER IF THEY PLAN TO LEAVE AN ORGANIZATION DURING THE COURSE OF A GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. CHANGES OF GREATER THAN 5% OF THE TOTAL YEARLY GRANT BUDGET BETWEEN OR INTO NEW BUDGET CATEGORIES ARE SUBJECT TO THE REVIEW AND APPROVAL. CONQUER CANCER REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (FINANCIAL REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND A BUDGET SUMMARY ARE REQUIRED TO BE SUBMITTED WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING THE END OF THE GRANT BUDGET PERIOD. CONQUER CANCER REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. CONQUER CANCER REQUIRES A FINAL PROJECT REPORT AND BUDGET SUMMARY WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING EXPIRATION OF THE GRANT. CONQUER CANCER REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED. GRANTS ARE ADMINISTRATIVELY CLOSED AFTER RECEIPT OF THE FINAL PROJECT REPORT AND FINAL BUDGET SUMMARY AND AFTER CONQUER CANCER'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS IN THE GRANT HAVE BEEN MET. CONQUER CANCER RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENT WITH THE APPROVED BUDGET. | ExplanationTxt |
Schedule G IRS990ScheduleG
| Field | Value | IRS element (for citing) |
|---|---|---|
| Mail Solicitations | Yes (X) | MailSolicitationsInd |
| Email Solicitations | Yes (X) | EmailSolicitationsInd |
| Phone Solicitations | Yes (X) | PhoneSolicitationsInd |
| In Person Solicitations | Yes (X) | InPersonSolicitationsInd |
| Solicitation Of Non Govt Grants | Yes (X) | SolicitationOfNonGovtGrantsInd |
| Special Fundraising Events | Yes (X) | SpecialFundraisingEventsInd |
| Agrmt Prof Fundraising Acty | Yes (true) | AgrmtProfFundraisingActyInd |
Fundraiser Activity Info FundraiserActivityInfoGrp (2 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | ActivityActivityTxt | Fundraiser Control Of FundsFundraiserControlOfFundsInd | Gross ReceiptsGrossReceiptsAmt | Retained By ContractorRetainedByContractorAmt | Net To OrganizationNetToOrganizationAmt |
|---|---|---|---|---|---|---|---|---|
| FAIRCOM NEW YORK | ||||||||
| 12 WEST 27TH STREET 13TH FLOOR | NEW YORK | NY | 10001 | GENERAL | false | $618,062 | $54,000 | $564,062 |
| TRUE NORTH | ||||||||
| 630 3RD AVENUE 12TH FLOOR | NEW YORK | NY | 10017 | FUNDRAISING STRATEGY | false | $0 | $168,000 | -$168,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Gross Receipts | $618,062 | TotalGrossReceiptsAmt |
| Total Retained By Contractors | $222,000 | TotalRetainedByContractorsAmt |
| Total Net To Organization | $396,062 | TotalNetToOrganizationAmt |
| Licensed States | AL | LicensedStatesCd |
| Licensed States | CA | LicensedStatesCd |
| Licensed States | CO | LicensedStatesCd |
| Licensed States | CT | LicensedStatesCd |
| Licensed States | DC | LicensedStatesCd |
| Licensed States | FL | LicensedStatesCd |
| Licensed States | GA | LicensedStatesCd |
| Licensed States | KS | LicensedStatesCd |
| Licensed States | KY | LicensedStatesCd |
| Licensed States | ME | LicensedStatesCd |
| Licensed States | MD | LicensedStatesCd |
| Licensed States | MA | LicensedStatesCd |
| Licensed States | MI | LicensedStatesCd |
| Licensed States | MS | LicensedStatesCd |
| Licensed States | NV | LicensedStatesCd |
| Licensed States | NH | LicensedStatesCd |
| Licensed States | NJ | LicensedStatesCd |
| Licensed States | NY | LicensedStatesCd |
| Licensed States | NC | LicensedStatesCd |
| Licensed States | ND | LicensedStatesCd |
| Licensed States | OK | LicensedStatesCd |
| Licensed States | OR | LicensedStatesCd |
| Licensed States | PA | LicensedStatesCd |
| Licensed States | RI | LicensedStatesCd |
| Licensed States | SC | LicensedStatesCd |
| Licensed States | TN | LicensedStatesCd |
| Licensed States | UT | LicensedStatesCd |
| Licensed States | WA | LicensedStatesCd |
| Licensed States | WI | LicensedStatesCd |
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | RESEARCH DINNER | Event1Nm |
| Gross Receipts Event1 | $1,010,938 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $904,765 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $106,173 | GrossRevenueEvent1Amt |
| Food And Beverage Event1 | $36,703 | FoodAndBeverageEvent1Amt |
| Other Direct Expenses Event1 | $43,424 | OtherDirectExpensesEvent1Amt |
| Event2 | SEPTEMBER SALON | Event2Nm |
| Gross Receipts Event2 | $99,689 | GrossReceiptsEvent2Amt |
| Charitable Contri Event2 | $99,689 | CharitableContriEvent2Amt |
| Other Events Total | 5 | OtherEventsTotalCnt |
| Gross Receipts Other Events | $125,656 | GrossReceiptsOtherEventsAmt |
| Charitable Contri Other Events | $125,656 | CharitableContriOtherEventsAmt |
| Gross Receipts Total | $1,236,283 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $1,130,110 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $106,173 | GrossRevenueTotalEventsAmt |
| Food And Beverage Total Events | $36,703 | FoodAndBeverageTotalEventsAmt |
| Oth Direct Expnss Total Events | $43,424 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $80,127 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | $26,046 | NetIncomeSummaryAmt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | FORM 990, SCHEDULE G, PART I, LINE 1 | FormAndLineReferenceDesc |
| Explanation | THE RETAINER FEES ARE PAID FOR THE WORK THAT FAIRCOM NY DOES ON MANAGING OUR ACCOUNT. THIS INCLUDES STRATEGY, COPY WRITING, LIST RECOMMENDATIONS, DATA ANALYSIS, ETC. THE OTHER FEES ARE FOR THE PRODUCTION OF THE ACTUAL MAILINGS THEMSELVES, POSTAGE, PRINTING, ACTUAL LIST RENTALS, ETC. TRUE NORTH PROVIDED DONOR STRATEGY CONSULTATION. | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (46 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt | Address Line1ForeignAddress/AddressLine1Txt | CountryForeignAddress/CountryCd |
|---|---|---|---|---|---|---|---|---|---|
| Cedars-Sinai Medical Center | |||||||||
| 8700 Beverly Blvd 1S35 | Los Angeles | CA | 90048 | 951644600 | 501(C)(3) | $450,000 | ACRA | ||
| Columbia University Medical Center | |||||||||
| 630 West 168th Street | New York | NY | 11042 | 135598093 | 501(C)(3) | $700,000 | CDA, YIA | ||
| Dana-Farber Cancer Institute | |||||||||
| 44 Binney St | Boston | MA | 022155450 | 042263040 | 501(C)(3) | $1,050,000 | CDA, YIA | ||
| Feinstein Institute Northwell Heath | |||||||||
| Monter Cancer Center | Lake Success | NY | 11042 | 112673595 | 501(C)(3) | $50,000 | YIA | ||
| Fred Hutchinson Cancer Research Center | |||||||||
| 1100 Fairview Ave N | Seattle | WA | 98109 | 237156071 | 501(C)(3) | $150,000 | YIA | ||
| Howard University | |||||||||
| 2400 Sixth Street NW | Washington | DC | 20059 | 530204707 | 501(C)(3) | $8,500 | MSR | ||
| Icahn School of Medicine at Mount Sinai | |||||||||
| 1 Gustave L Levy Pl | New York | NY | 100293294 | 136171197 | 501(C)(3) | $100,000 | YIA | ||
| Indiana University | |||||||||
| 420 University Boulevard | Indianapolis | IN | 46202 | 356001673 | 501(C)(3) | $200,000 | CDA | ||
| Joan & Sanford I Weill Medical College of Cornell | |||||||||
| 525 East 68th Street | New York | NY | 10065 | 131623978 | 501(C)(3) | $165,000 | LIFE, YIA | ||
| Johns Hopkins University | |||||||||
| 3400 N Charles Street | Baltimore | MD | 212182608 | 520595110 | 501(C)(3) | $450,000 | CDA, YIA | ||
| Maine Medical Center | |||||||||
| 22 Bramhall Street | Portland | ME | 041023175 | 010238552 | 501(C)(3) | $50,000 | YIA | ||
| Massachusetts General Hospital | |||||||||
| 55 Fruit Street | Boston | MA | 02114 | 042697983 | 501(C)(3) | $450,000 | CDA, YIA | ||
| Mayo Clinic | |||||||||
| 200 1st street SW | Rochester | MN | 55905 | 416011702 | 501(C)(3) | $100,000 | YIA | ||
| Morehouse School of Medicine | |||||||||
| 720 Westview Drive SW | Atlanta | GA | 303101495 | 581438873 | 501(C)(3) | $8,500 | MSR | ||
| Ochsner Clinic Foundation | |||||||||
| 1514 Jefferson Highway BH 546 | New Orleans | LA | 70121 | 720502505 | 501(C)(3) | $50,000 | YIA | ||
| Rhode Island Hospital | |||||||||
| 593 Eddy St | Providence | RI | 029034923 | 050258809 | 501(C)(3) | $50,000 | YIA | ||
| Roswell Park Comprehensive Cancer Center | |||||||||
| Elm Carlton Streets | Buffalo | NY | 14263 | 114140215 | 501(C)(3) | $50,000 | YIA | ||
| San Juan Bautista School of Medicine | |||||||||
| 660361341 | 501(C)(3) | $8,500 | MSR | CAGUAS | RQ | ||||
| Sarah Cannon Research Institute | |||||||||
| 3322 West End AvenueSuite 900 | Nashville | TN | 37203 | 201557751 | 501(C)(3) | $50,000 | YIA | ||
| Scripps Translational Science Institute | |||||||||
| 3344 North Torrey Pines Court Suit | La Jolla | CA | 92307 | 330435954 | 501(C)(3) | $50,000 | YIA | ||
| Seattle Children's Hospital dba Seattle Children's | |||||||||
| Suite 300 | Seattle | WA | 98115 | 910564748 | 501(C)(3) | $50,000 | YIA | ||
| Sloan Kettering Institute for Cancer Research | |||||||||
| 1275 York Avenue | New York | NY | 10065 | 131624182 | 501(C)(3) | $707,847 | CDA, YIA | ||
| St Jude Children's Research Hospital | |||||||||
| 262 Danny Thomas Place | Memphis | TN | 38105 | 620646012 | 501(C)(3) | $150,000 | YIA | ||
| Stanford University | |||||||||
| 800 Welch Road | Stanford | CA | 94305 | 941156365 | 501(C)(3) | $17,000 | MSR | ||
| SUNY Upstate Medical University | |||||||||
| 750 E Adams Street | Syracuse | NY | 13210 | 141438361 | 501(C)(3) | $8,500 | MSR | ||
| Texas Tech University Health Sciences Center El Pa | |||||||||
| 5001 El Paso Drive | El Paso | TX | 79905 | 752668018 | 501(C)(3) | $8,500 | MSR | ||
| The Children's Hospital of Philadelphia | |||||||||
| 34th Street and Civic Center Boulev | Philadelphia | PA | 19104 | 231352166 | 501(C)(3) | $50,000 | YIA | ||
| The University of Alabama at Birmingham | |||||||||
| 1720 2nd Avenue South | Birmingham | AL | 35233 | 636005396 | 501(C)(3) | $200,000 | YIA | ||
| The University of Chicago | |||||||||
| 5841 S Maryland Ave | Chicago | IL | 60637 | 362177139 | 501(C)(3) | $50,000 | YIA | ||
| The University of North Carolina at Chapel Hill | |||||||||
| 102 Mason Farm Rd | Chapel Hill | NC | 275997295 | 566001393 | 501(C)(3) | $150,000 | YIA | ||
| The University of Texas MD Anderson Cancer Center | |||||||||
| 1515 Holcombe Blvd | Houston | TX | 77030 | 746001118 | 501(C)(3) | $700,000 | CDA, YIA | ||
| Tufts University School of Medicine | |||||||||
| 136 Harrison Avenue | Boston | MA | 021111817 | 042103634 | 501(C)(3) | $8,500 | MSR | ||
| UCSF Benioff Children's Hospital Oakland | |||||||||
| 747 52nd Street | Oakland | CA | 94609 | 940382330 | 501(C)(3) | $50,000 | YIA | ||
| University of Arizona | |||||||||
| 888 N Euclid Ave Room 510 | Tucson | AZ | 85719 | 742652689 | 501(C)(3) | $8,500 | MSR | ||
| University of California San Diego | |||||||||
| 3855 Health Sciences Drive | La Jolla | CA | 92093 | 956006144 | 501(C)(3) | $100,000 | YIA | ||
| University of California Davis | |||||||||
| 1850 Research Park Dr | Davis | CA | 95618 | 946036494 | 501(C)(3) | $50,000 | YIA | ||
| University of California San Francisco | |||||||||
| 2340 Sutter Street | San Francisco | CA | 941150128 | 946036493 | 501(C)(3) | $50,000 | YIA | ||
| University of Minnesota | |||||||||
| 450 McNamara Alumni Center | Minneapolis | MN | 55455 | 416007513 | 501(C)(3) | $50,000 | YIA | ||
| University of Pennsylvania | |||||||||
| 16th Floor Penn Tower | Philadelphia | PA | 191044283 | 231352685 | 501(C)(3) | $150,000 | YIA | ||
| University of Pittsburgh | |||||||||
| 5150 Centre Avenue | Pittsburgh | PA | 15232 | 250965591 | 501(C)(3) | $250,000 | CDA, YIA | ||
| University of South Alabama | |||||||||
| 307 University Blvd | Mobile | AL | 366880002 | 630477348 | 501(C)(3) | $8,500 | MSR | ||
| University of Southern California | |||||||||
| 3720 S Flower St | Los Angeles | CA | 900890701 | 951642394 | 501(C)(3) | $50,000 | YIA | ||
| University of Washington | |||||||||
| 4333 Brooklyn Ave NE | Seattle | WA | 981959472 | 916001537 | 501(C)(3) | $50,000 | YIA | ||
| University of Wisconsin | |||||||||
| 21 N Park Street | Madison | WI | 537151218 | 396006492 | 501(C)(3) | $50,000 | YIA | ||
| Washington University | |||||||||
| Campus Box 1054 | St Louis | MO | 631304862 | 430653611 | 501(C)(3) | $50,000 | YIA | ||
| Winship Cancer Institute of Emory University | |||||||||
| 525 East 68th Street | New York | NY | 10065 | 131623978 | 501(C)(3) | $50,000 | YIA | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 46 | Total501c3OrgCnt |
Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (4 entries)
| Grant TypeGrantTypeTxt | RecipientRecipientCnt | Cash GrantCashGrantAmt |
|---|---|---|
| Merit Awards | 202 | $202,000 |
| Patient Advocate Scholarships | 22 | $39,600 |
| Medical Student Rotation Award | 23 | $87,500 |
| Resident Travel Award | 6 | $9,000 |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 1 | CONQUER CANCER GRANTS ARE AWARDED BASED ON MERIT THROUGH A PEER-REVIEW PROCESS CONDUCTED BY MEMBERS OF CONQUER CANCER'S GRANT SELECTION COMMITTEE USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH SPECIFIC GRANT. GRANTEES ARE REQUIRED TO SIGN A GRANT AGREEMENT THAT ESTABLISHES CERTAIN REQUIREMENTS FOR THE GRANT. GRANTEES MUST REQUEST APPROVAL FOR ANY CHANGES IN THE GRANT PROJECT AND THE GRANTEE'S STATUS. GRANTEES MUST SUBMIT A FORMAL REQUEST FOR A CHANGE IN OBJECTIVES OR SCOPE TO CCF AND INCLUDE JUSTIFICATION FOR THE CHANGES, WHICH IS SUBJECT TO CONQUER CANCER'S REVIEW AND APPROVAL. GRANTEES ARE REQUIRED TO NOTIFY CONQUER CANCER AND REQUEST A NO-COST EXTENSION IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT OR TO MEET THE PROPOSED TIME SCHEDULES. GRANTEES ARE REQUIRED TO NOTIFY CONQUER CANCER IF THEY PLAN TO LEAVE AN ORGANIZATION DURING THE COURSE OF A GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. CHANGES OF GREATER THAN 5% OF THE TOTAL YEARLY GRANT BUDGET BETWEEN OR INTO NEW BUDGET CATEGORIES ARE SUBJECT TO THE REVIEW AND APPROVAL. CONQUER CANCER REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (FINANCIAL REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND A BUDGET SUMMARY ARE REQUIRED TO BE SUBMITTED WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING THE END OF THE GRANT BUDGET PERIOD. CONQUER CANCER REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. CONQUER CANCER REQUIRES A FINAL PROJECT REPORT AND BUDGET SUMMARY WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING EXPIRATION OF THE GRANT. CONQUER CANCER REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED. GRANTS ARE ADMINISTRATIVELY CLOSED AFTER RECEIPT OF THE FINAL PROJECT REPORT AND FINAL BUDGET SUMMARY AND AFTER CCF'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS IN THE GRANT HAVE BEEN MET. CONQUER CANCER RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENTLY WITH THE APPROVED BUDGET. |
| part II, award abbreviations: | YIA: Young investigator award CDA: Career Development award MSR: Medical Student Rotation ACRA: Advanced Clinical REsearch award |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Severance Payment | false | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | false | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | false | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (3 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clifford Hudis MD FACP | ||||||||||||||
| CEO | $0 | $818,627 | $0 | $79,567 | $0 | $0 | $0 | $21,000 | $0 | $3,233 | $0 | $922,427 | $0 | |
| Nancy Daly MS MPH | ||||||||||||||
| EXEC VP & CHIEF PHILAN OFFICER | $0 | $380,173 | $0 | $7,500 | $0 | $0 | $21,000 | $0 | $17,537 | $0 | $426,210 | $0 | $0 | |
| LINDA JENSEN CPA | ||||||||||||||
| CFO | $0 | $394,424 | $0 | $7,500 | $0 | $0 | $21,000 | $0 | $17,536 | $0 | $440,460 | $0 | $0 | |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 3: | FormAndLineReferenceDesc |
| Explanation | EXPLANATION: COMPENSATION IS ESTABLISHED BY A RELATED ORGANIZATION, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. THE METHODS USED BY ASCO TO DETERMINE COMPENSATION ARE: COMPENSATION COMMITTEE; INDEPENDENT COMPENSATION CONSULTANT; FORMS 990 OF OTHER ORGANIZATIONS, WRITTEN EMPLOYMENT CONTRACT; COMPENSATION STUDY OR SURVEY; AND APPROVAL BY BOARD OR COMPENSATION COMMITTEE. | ExplanationTxt |
Schedule M IRS990ScheduleM
Works Of Art WorksOfArtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 2 | ContributionCnt |
| Noncash Contributions Rpt F990 | $1,525 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | FMV | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Art Historical Treasures | ArtHistoricalTreasuresGrp | |
| Art Fractional Interest | ArtFractionalInterestGrp | |
| Books And Publications | BooksAndPublicationsGrp | |
| Clothing And Household Goods | ClothingAndHouseholdGoodsGrp | |
| Cars And Other Vehicles | CarsAndOtherVehiclesGrp | |
| Boats And Planes | BoatsAndPlanesGrp | |
| Intellectual Property | IntellectualPropertyGrp |
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 18 | ContributionCnt |
| Noncash Contributions Rpt F990 | $1,889,349 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | FMV | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities Closely Held Stock | SecuritiesCloselyHeldStockGrp | |
| Secur Prtnrshp Trust Intrsts | SecurPrtnrshpTrustIntrstsGrp | |
| Securities Miscellaneous | SecuritiesMiscellaneousGrp | |
| Qualified Contrib Hist Struct | QualifiedContribHistStructGrp | |
| Qualified Contrib Other | QualifiedContribOtherGrp | |
| Real Estate Residential | RealEstateResidentialGrp | |
| Real Estate Commercial | RealEstateCommercialGrp | |
| Real Estate Other | RealEstateOtherGrp | |
| Collectibles | CollectiblesGrp | |
| Food Inventory | FoodInventoryGrp | |
| Drugs And Medical Supplies | DrugsAndMedicalSuppliesGrp | |
| Taxidermy | TaxidermyGrp | |
| Historical Artifacts | HistoricalArtifactsGrp | |
| Scientific Specimens | ScientificSpecimensGrp | |
| Archaeological Artifacts | ArchaeologicalArtifactsGrp |
Other Non Cash Contri Table OtherNonCashContriTableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Desc | VARIOUS SILENT AUCTION ITEMS | Desc |
| Contribution | 60 | ContributionCnt |
| Noncash Contributions Rpt F990 | $104,648 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | FMV | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (true) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | false | ThirdPartiesUsedInd |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (9 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART III, LINE 4D, OTHER PROGRAM SERVICES | PATIENT EDUCATION AND INFORMATION - WELL-INFORMED, EDUCATED PATIENTS ARE THEIR OWN BEST ADVOCATES, AS WELL AS INVALUABLE PARTNERS FOR DOCTORS. CONQUER CANCER SUPPORTS PROGRAMS AND ACCURATE, DOCTOR-APPROVED CANCER INFORMATION AND RESOURCES BOTH IN PRINT AND ONLINE, THAT EDUCATE PATIENTS AND THE PUBLIC ABOUT CANCER CARE, TREATMENT, RESEARCH, PREVENTION, AND OTHER ISSUES IMPORTANT TO THE CANCER COMMUNITY. FUNDING IN THIS AREA ALLOWS CONQUER CANCER TO CONTINUE AND EXPAND OUR WORK TO INFORM PATIENTS. HIGHLIGHTS OF PATIENT EDUCATION AND INFORMATION PROGRAMS AND ACTIVITIES SUPPORTED BY CONQUER CANCER IN 2019 INCLUDE THE FOLLOWING: PATIENT ADVOCATE SCHOLARSHIP PROGRAM- THE PATIENT ADVOCATE SCHOLARSHIP PROGRAM PROVIDES THE OPPORTUNITY FOR ADVOCATES TO ATTEND ASCOS SCIENTIFIC MEETINGS TO GAIN THE EDUCATION, KNOWLEDGE, AND SKILLS NECESSARY TO PARTICIPATE IN PATIENT ADVOCACY AND THE CANCER RESEARCH PROCESS. THE SCHOLARSHIPS ALSO ENABLE ADVOCATES TO PROMOTE THEIR ORGANIZATIONS PROGRAMS, SERVICES, AND RESOURCES AND TO NETWORK WITH ONE ANOTHER AS WELL AS WITH ONCOLOGY PROFESSIONALS. IN 2019, $186,284 IN FUNDING ALLOWED 65 PATIENT ADVOCATES TO ATTEND THE ASCO MEETINGS. CANCER.NET- CANCER.NET BRINGS THE EXPERTISE AND RESOURCES OF ASCO TO PEOPLE LIVING WITH CANCER AND THOSE WHO CARE FOR AND CARE ABOUT THEM. THE WEBSITE PROVIDES TIMELY, COMPREHENSIVE INFORMATION TO HELP PATIENTS AND FAMILIES MAKE INFORMED HEALTH CARE DECISIONS. ALL CONTENT IS SUBJECT TO A FORMAL PEER-REVIEW PROCESS BY THE CANCER.NET EDITORIAL BOARD, COMPOSED OF MORE THAN 150 MEDICAL, SURGICAL, RADIATION, AND PEDIATRIC ONCOLOGISTS, PHYSICIAN ASSISTANTS, ONCOLOGY NURSES, SOCIAL WORKERS, AND PATIENT ADVOCATES AND INCLUDES PEER-REVIEWED INFORMATION ON MORE THAN 120 TYPES OF CANCER AND SYNDROMES, INCLUDING RISK FACTORS, DIAGNOSIS, FINDING AN ONCOLOGIST, TREATMENT, MANAGING SIDE EFFECTS, CLINICAL TRIALS, AND AFTER TREATMENT, CAREGIVING, COPING STRATEGIES, AND SURVIVORSHIP. INFORMATION IS DELIVERED IN WRITTEN ARTICLES, VIDEOS, AND AUDIO PODCASTS. THIS INFORMATION IS MADE AVAILABLE FREE TO THE PUBLIC. |
| FORM 990, PART VI, SECTION A, LINE 1 | AS OF DECEMBER 31, 2018, THE BOARD OF DIRECTORS OF CONQUER CANCER INCLUDED SIXTEEN (16) DIRECTORS WITH VOTING RIGHTS, AND TWO (2) WITHOUT VOTING RIGHTS. ALL VOTING MEMBERS OF THE BOARD OF DIRECTORS HAVE THE SAME VOTING RIGHTS. DURING THE REPORTED TAX YEAR, THE BOARD OF DIRECTORS DELEGATED AUTHORITY TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS CONSISTENT WITH CONQUER CANCER'S BYLAWS. THE EXECUTIVE COMMITTEE IS COMPOSED OF SIX MEMBERS OF THE BOARD OF DIRECTORS, WHO ARE THE CHAIR OF THE BOARD OF DIRECTORS, THE CEO, THE SECRETARY, THE TREASURER, THE EXECUTIVE VICE PRESIDENT AND CHIEF PHILANTHOPIC OFFICER (NON-VOTING), AND A SIXTH DIRECTOR WHO IS NOMINATED BY THE CHAIR OF THE BOARD AND ELECTED BY A MAJORITY OF THE VOTING MEMBERS OF THE BOARD OF DIRECTORS. ALL OF THE MEMBERS OF THE EXECUTIVE COMMITTEE EXCEPT THE EXECUTIVE VICE PRESIDENT AND CHIEF PHILANTHROPIC OFFICER ARE ENTITLED TO VOTE. THE SCOPE OF THE EXECUTIVE COMMITTEE'S AUTHORITY IS ESTABLISHED BY CONQUER CANCER'S BYLAWS, WHICH PROVIDE THAT EXCEPT TO THE EXTENT SPECIFICALLY PROHIBITED BY RESOLUTION OF THE BOARD OF DIRECTORS OR OTHERWISE PROHIBITED BY LAW AND EXCEPT AS SPECIFIED IN THE BYLAWS, THE EXECUTIVE COMMITTEE OF THE BOARD IS EMPOWERED TO MAKE AND IMPLEMENT DECISIONS BETWEEN BOARD MEETINGS AND IT MAY ACT ON ITEMS REQUIRING ACTION PRIOR TO THE NEXT ANNOUNCED BOARD MEETING. ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO THE BOARD OF DIRECTORS AT THE MEETING OF THE BOARD OF DIRECTORS IMMEDIATELY FOLLOWING THE ACTION TAKEN BY THE EXECUTIVE COMMITTEE, CONSISTENT WITH CONQUER CANCER'S BYLAWS. |
| FORM 990, PART VI, SECTION A, LINE 2 | DR. CLIFFORD HUDIS, NANCY DALY, AND LINDA JENSEN WERE ALL EMPLOYED BY ASCO. DR. CLIFFORD HUDIS, DR. HOWARD BURRIS, AND DR. THOMAS ROBERTS, JR. ALL SERVED ON THE ASCO BOARD OF DIRECTORS DURING 2019. |
| FORM 990, PART VI, SECTION A, LINE 7A | CONQUER CANCER DOES NOT HAVE MEMBERS. DIRECTORS OF CONQUER CANCER ARE APPOINTED AND SUBJECT TO REMOVAL BY THE BOARD OF DIRECTORS OF ASCO, EXCEPT FOR DIRECTORS SERVING EX-OFFICIO. |
| FORM 990, PART VI, SECTION A, LINE 7B | THE BOARD OF DIRECTORS OF CONQUER CANCER MAY VOTE TO AMEND OR REPEAL THE BYLAWS OF CONQUER CANCER, BUT THE BOARD OF DIRECTORS OF ASCO MUST APPROVE AN AMENDMENT OR REPEAL OF THE BYLAWS TO BE EFFECTIVE. CONQUER CANCER MAY NOT AMEND ITS ARTICLES OF INCORPORATION WITHOUT PROVIDING TO ASCO WRITTEN NOTICE OF THE PROPOSED AMENDMENT AT LEAST THIRTY (30) DAYS IN ADVANCE. |
| FORM 990, PART VI, SECTION B, LINE 11B | AN ELECTRONIC COPY OF THE CONQUER CANCER FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS BEFORE IT WAS FILED. THE CONQUER CANCER FORM 990 WAS REVIEWED BY THE CHIEF FINANCIAL OFFICER, THE EXECUTIVE VICE PRESIDENT AND CHIEF PHILANTHROPIC OFFICER, THE CEO, AND THE GENERAL COUNSEL PRIOR TO FILING. |
| FORM 990, PART VI, SECTION B, LINE 12C | CONQUER CANCER MAINTAINS A NUMBER OF WRITTEN CONFLICT OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL CONQUER CANCER STAFF, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND ANY PERSON IN A RELATIONSHIP WITH THESE INDIVIDUALS INVOLVING THE SHARING OF INCOME OR ASSETS (E.G., SPOUSE, DEPENDENT CHILDREN). UNDER CONQUER CANCER'S POLICIES, COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS,CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE, AND UPDATED ANNUALLY THEREAFTER OR WHEN ANY MATERIAL CHANGES OCCUR. CONQUER CANCER'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, WHEN CONQUER CANCER IS CONTEMPLATING ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY "INTERESTED PERSON" (I.E., A CONQUER CANCER DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF A COMMITTEE WITH BOARD DELEGATED POWERS WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERNATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. |
| FORM 990, PART VI, SECTION B, LINES 15A & 15B | THE FOLLOWING EMPLOYEES OF ASCO SERVE AS OFFICERS OF CONQUER CANCER: CEO OF CONQUER CANCER (ALSO SERVES AS CEO OF ASCO) EXECUTIVE VICE PRESIDENT AND CHIEF PHILANTHROPIC OFFICER OF CONQUER CANCER CFO OF CONQUER CANCER INFORMATION REGARDING THEIR COMPENSATION AND THE PROCESS FOR DETERMINING THEIR COMPENSATION ARE DESCRIBED IN THE IRS FORM 990 OF ASCO. CONQUER CANCER STAFF ARE EMPLOYEES OF ASCO WHO ARE LEASED TO CONQUER CANCER. APPLICABLE INFORMATION REGARDING THEIR COMPENSATION IS DESCRIBED IN THE IRS FORM 990 OF ASCO. CONQUER CANCER DOES NOT PAY COMPENSATION TO THESE INDIVIDUALS. |
| FORM 990, PART VI, SECTION C, LINE 19 | CONQUER CANCER'S GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC FROM CONQUER CANCER UPON REQUEST. CONQUER CANCER'S ARTICLES OF INCORPORATION ARE ALSO AVAILABLE TO THE PUBLIC THROUGH THE VIRGINIA STATE CORPORATION COMMISSION. CONFLICT OF INTEREST POLICIES AND STANDARDS ARE POSTED ON CONQUER CANCER'S WEBSITE. THE ANNUAL REPORT OF CONQUER CANCER IS POSTED ON CONQUER CANCER'S WEBSITE AND IS AVAILABLE TO THE PUBLIC FROM CONQUER CANCER UPON REQUEST. THE AUDITED FINANCIAL STATEMENTS OF CONQUER CANCER ARE POSTED ON CONQUER CANCER'S WEBSITE. |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (2 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Controlled OrganizationControlledOrganizationInd |
|---|---|---|---|---|---|---|---|---|---|---|
| AMERICAN SOCIETY OF CLINICAL ONCOLOGY | ||||||||||
| 2318 MILL RD 800 | ALEXANDRIA | VA | 22314 | 136180380 | education | NY | 501(C)(3) | 10 | NA | false |
| ASCO ASSOCIATION | ||||||||||
| 2318 MILL ROAD | ALEXANDRIA | VA | 22314 | 833561693 | MEMBER SERV. | VA | 501(C)(6) | ASCO | false | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | false | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | Yes (true) | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (true) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | Yes (true) | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | false | DivRelatedOrganizationInd |
| Asset Sale To Other Org | false | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | false | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | Yes (true) | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | Yes (true) | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | Yes (true) | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | Yes (true) | SharingOfFacilitiesInd |
| Paid Employees Sharing | Yes (true) | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | Yes (true) | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | Yes (true) | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | false | TransferToOtherOrgInd |
| Transfer From Other Org | false | TransferFromOtherOrgInd |
Comments